Could a BJP-led India mean impetus for pharma?
This article was originally published in Scrip
Executive Summary
A business friendly environment and policies that support the lifesciences sector, including a balanced approach in generally thorny areas such as foreign direct investment (FDI), may well be on the cards if the Hindu nationalist Bharatiya Janata Party (BJP) comes to power in India, according to pharma industry pundits.